Abstract
Angiosarcoma accounts for <2% of all soft-tissue sarcomas, and weekly paclitaxel treatment offers clinical benefits and good tolerance. Kasabach–Merritt syndrome (KMS) is a consumptive coagulopathy status associated with vascular tumors. We report a case of hepatic angiosarcoma complicated with KMS who achieved good control in about 2 months under weekly paclitaxel. We also discuss the presentation, diagnosis, and treatment of angiosarcoma with KMS and bone marrow involvement.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
